SEC Form 4 · accession 0001209191-17-002482
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D Bluth
Officer — EVP of Investor Relations
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 9:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $3.00 | Jan 3, 2017 | A | 75,000 | A | — | Jan 2, 2027 | Common Stock | 75,000 | 75,000 | D |
| Restricted Stock UnitsF3,F4 | — | Jan 3, 2017 | A | 25,000 | A | — | — | Common Stock | 25,000 | 25,000 | D |
| Employee Stock Option (Right to Buy)F1 | $24.14 | holding | — | — | — | — | Aug 5, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option vests according to the following schedule: 1/4th of the shares vest on 08/01/2017; and 1/36th of the remaining shares vest at the end of each month over the next 36 months.
- F2The option vests according to the following schedule: 1/48th of the shares shall vest at the end of each month over 48 months, beginning after 01/01/2017.
- F3Each restricted stock unit represents a contingent right to receive one share of Cempra, Inc. common stock.
- F4The restricted stock units vest in full on January 1, 2019, subject to continued employment, or upon termination without cause.